Aurinia Pharma GAAP EPS of $1.53 beats by $1.31, revenue of $77.1M beats by $2.4M

Aurinia Pharma announced a GAAP EPS of $1.53, significantly beating estimates by $1.31, with revenue of $77.1 million also exceeding expectations by $2.4 million.